Initial Phase NT-proBNP, but Not Copeptin and High-Sensitivity Cardiac Troponin-T Yielded Diagnostic and Prognostic Information in Addition to Clinical Assessment of Out-of-Hospital Cardiac Arrest Patients With Documented Ventricular Fibrillation.

Front Cardiovasc Med · 2018 · PMC6001003 · PMID 29930943

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The only biomarker demonstrating a highly significant difference in this study population was NT-proBNP; Group 4 having a significantly higher mean value of 405.1 pmol/L (SD 569.9) as compared to the other two groups ( p = 0.001) ( Table 3 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.